Merck (MRK) Assets (2009 - 2026)
Merck (MRK) reported Assets of $129.8 billion for Q2 2026, up 10.4% from $117.52 billion a year earlier and up 0.9% from the prior quarter.
Analysis
Merck (MRK) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Merck posted Assets of $136.87 billion, up 16.9% from FY2024.
- Assets has a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- By year, Assets came in at $117.11 billion in FY2024 (+9.8%), $106.68 billion in FY2023 (-2.3%), $109.16 billion in FY2022 (+3.3%) and $105.69 billion in FY2021 (+15.4%).
- Five-year quarterly Assets spans a low of $93.49 billion in Q3 2021 and a high of $136.87 billion in Q4 2025.
- Year over year, Assets has now increased in each of the last nine quarters, with growth averaging 10.3% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2022 (growth of 18.1%); the low point was Q2 2023 (a decline of 2.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $128.69 billion (Q1 2026), $136.87 billion (Q4 2025) and $129.55 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 87.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.80 Bn |
| Mar 31, 2026 | 128.69 Bn |
| Dec 31, 2025 | 136.87 Bn |
| Sep 30, 2025 | 129.55 Bn |
| Jun 30, 2025 | 117.52 Bn |
| Mar 31, 2025 | 115.12 Bn |
| Dec 31, 2024 | 117.11 Bn |
| Sep 30, 2024 | 117.53 Bn |
| Jun 30, 2024 | 112.63 Bn |
| Mar 31, 2024 | 105.85 Bn |
| Dec 31, 2023 | 106.68 Bn |
| Sep 30, 2023 | 106.73 Bn |
| Jun 30, 2023 | 104.47 Bn |
| Mar 31, 2023 | 107.80 Bn |
| Dec 31, 2022 | 109.16 Bn |
| Sep 30, 2022 | 107.08 Bn |
| Jun 30, 2022 | 107.10 Bn |
| Mar 31, 2022 | 106.67 Bn |
| Dec 31, 2021 | 105.69 Bn |
| Sep 30, 2021 | 93.49 Bn |
API Access
Merck Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MRK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MRK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MRK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();